Page 91 - IngresoDr.MtzLanao

Riegelman S, Loo JCK, Rowland M (1968). Shortcommings in pharmacokinetic analysis by
conceiving by the body exhibit properties of a single compartment. J Pharm Sci., 57: 117-123.

Robles-Martinez P, Xu X, Trenfield SJ, Awad A, Goyanes A, Telford R, et al (2019). 3D printing of
a multi-layered polypill containing six drugs using a novel stereolithographic method.
Pharmaceutics., 11(6): 274.

Rodríguez-Nogales C, González-Fernández Y, Aldaz A, Couvreur P, Blanco-Prieto MJ (2018).
Nanomedicines for Pediatric Cancers. ACS Nano., 12(8): 7482-7496.

Rodríguez Nozal, R (2017). La construcción de una industria farmacéutica autosuficiente en la
España de la Autarquía: entre la necesidad, la utopía y la propaganda franquista. Asclepio, 69
(1): 173.

Roggo Y, Jelsch M, Heger P, Ensslin S, Krumme M (2020). Deep learning for continuous
manufacturing of pharmaceutical solid dosage form. Eur J Pharm Biopharm., 153: 95-105.

Rowland M, Tozer TN (1981). Clinical pharmacokinetics: concepts and applications Lea &
Febiger. Washington.

Rowland M, Riegelman S, Epstein WL (1968). Absorption kinetics of griseofulvin in man. J Pharm
Sci., 5: 984-989.

Rowland M, Riegelman S, Harris PA, Sholkoff SD. Eyring EJ (1967). Kinetic of acetylsalicilic acid
disposition in man. Nature., 215: 413-414.

Sachs E, Cima M, Williams P, Brancazio D, Cornie J (1992). Three dimensional printing: Rapid
tooling and prototypes directly from a CAD model. J Manuf Sci Eng., 114: 481–488.

Sadia, M, Sosnicka A, Arafat B, Isreb A. Ahmed W, Kelarakis A, Alhnan MA (2016). Adaptation of
pharmaceutical excipients to FDM 3D printing for the fabrication of patient-tailored immediate
reléase tablets. Int J Pharm., 513: 659–668.

Sayalero ML, Maderuelo C (2017). Formas sólidas orales de liberación inmediata (Capítulo 2)
(Vol III pp 47-111). R Martínez Pacheco (Ed). En Tratado de Tecnología Farmacéutica (vol. III):
Formas de Dosificación. Editorial Síntesis.

Schmidt S, Kim S, Vozmediano V, Cristofoletti R, Winterstein AG, Brown JD (2019).
Pharmacometrics, Physiologically Based Pharmacokinetics, Quantitative Systems
Pharmacology-What's Next?-Joining Mechanistic and Epidemiological Approaches.CPT
Pharmacometrics Syst Pharmacol., 8(6): 352-355.

Scott Crump S. U.S. Patent 5,121,329 (1989), "Apparatus and Method for Creating Three-
Dimensional Objects" (A system and a method for building three-dimensional objects in a layer-
by-layer manner via fused deposition modeling).

Sheiner LB, Rosenberg B, Marathe VV (1977). Estimation of population characteristics of
pharmacokinetic parameters from routine clinical data. J. Pharmacokin. Biopharm., 5: 445-479.

Sheiner LB, Beal SL (1982). Bayesian individualization of pharmacokinetics: simple
implementation and comparison with non-Bayesian methods. J Pharm Sci. 71(12):1344-1348.

89